Transferred melanoma-specific CD8 ⁺ T cells persist, mediate tumor regression, and acquire central memory phenotype

Aude G. Chapuis, John A. Thompson, Kim Margolin, +9

Proceedings of the National Academy of Sciences

Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood

Jayasri G. Iyer, Olga K. Afanasiev, Christopher L. McClurkan, +13

Clinical Cancer Research

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Seth M. Pollack, Achim A. Jungbluth, Benjamin Hoch, +9

Cancer

T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

Aude G. Chapuis, Ilana M. Roberts, John A. Thompson, +12

Journal of Clinical Oncology

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells

Seth M. Pollack, Robin L. Jones, Erik Farrar, +15

Journal for ImmunoTherapy of Cancer

NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine

Seth M. Pollack, Yonqing Li, Megan J. Blaisdell, +9

PLoS ONE

IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy

Karan Kohli, Yao Lu, Theodore S. Nowicki, +19

Journal for ImmunoTherapy of Cancer